![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, August 31, 2013 12:21:43 PM
I do like the $1 target by the end of Q1...sounds reasonable to me. The MANF program has a multi faceted layer of possibilities. More importantly, it sounds like there are 6 potential platforms:
1) Retinitis Pigmentosa
2) Diabetes
3) TBI (Traumatic brain injury)
4) Parkinson's
5) Ischemic Heart Disease
6) ???
Any ideas of the sixth area (some have speculated there are at least six)?
GLTA!!!
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM